-
'Breast cancer enters age of precision: a happy concern for Korean clinicians'
21 Jul 2025 06:08 GMT
… HER2-) breast cancer is the most common subtype among breast cancer patients. … used appropriately, the prognosis for patients can be … HR+/HER2-) breast cancer patients with PIK3CA mutations. … the triple-negative breast cancer barrier
Trodelvy’s innovation …
-
Quercetin: A Natural Ally in Combating Breast Cancer
18 Jul 2025 12:57 GMT
… recurrence, and a significantly worse prognosis compared to other subtypes.4 … -suppression of tumor microenvironment for breast tumor-bearing mice. Sci Rep. … targeted radiotherapy in treatment of breast cancer. Breast Cancer. 2022;16:11782234221086728. doi: …
-
Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy
18 Jul 2025 12:57 GMT
… chemotherapy in breast cancer patients. Clin Breast Cancer. 2020; … in early-stage breast cancer. Breast Cancer Res Treat. 2023 … to poorer prognosis among metastatic breast cancer patients receiving … breast cancer for assessment in small biopsies. Breast Cancer …
-
US FDA grants breakthrough therapy designation to Daiichi Sankyo & AstraZeneca’s Enhertu plus pertuzumab to treat unresectable or metastatic HER2 positive breast cancer
18 Jul 2025 08:35 GMT
… HER2 positive breast cancer.
Enhertu … breast cancer, later-line HER2 positive metastatic breast cancer, later-line HER2 low metastatic breast cancer … metastatic breast cancer is an … breast cancer.6 While HER2 targeted therapies have improved outcomes, prognosis …
-
If approved, Kisqali will intensify competition in early-stage breast cancer drug prescription
18 Jul 2025 04:42 GMT
… adjuvant therapy after early breast cancer surgery.
Health insurance … breast cancer is known to have a high survival rate, but the prognosis … study in metastatic breast cancer demonstrated clinical utility … expansion in early breast cancer based on appropriate …
-
Enhertu Combo Receives FDA Designation in Metastatic HER2+ Breast Cancer
18 Jul 2025 03:07 GMT
… or metastatic HER2-positive breast cancer, according to a … progression or death. The prognosis for this disease remains … with metastatic HER2-positive breast cancer," Tolaney concluded in … with HER2 Positive Metastatic Breast Cancer." News Release. …
-
Breast cancer metastasis test arrives in hospitals: "It's invaluable."
17 Jul 2025 21:48 GMT
… predicts the prognosis of patients with breast cancer and helps … Center, and the International Breast Cancer Center, all in Barcelona. … 80% of patients with breast cancer had MAF-negative tumors, … women with early-stage breast cancer.
After so much suffering …
-
Study Finds HER2-Negative Outperforms HER2-Low in Neoadjuvant Chemotherapy Response in Breast Cancer
17 Jul 2025 20:47 GMT
… stage breast cancer. The findings, published in Breast Cancer Research, … a prognostic factor in early-stage breast cancer and … in early-stage breast cancer. Additionally, multivariate … HER2 status in breast cancer. Breast Cancer Research Foundation. Accessed …
-
Preoperative Neutrophil-to-Albumin Ratio as a Prognostic Indicator in Advanced Gastric Cancer Undergoing Radical Gastrectomy
19 Jul 2025 11:24 GMT
… reliable and accessible prognostic biomarkers for accurate … to determine independent prognostic variables. Statistical significance … enhance prognostic precision. Such combined prognostic models … SIRI) in patients with breast cancer: a meta-analysis. …
-
MiR-499a-5p Promotes the Proliferation and Migration of Uterine Leiomyoma Cells by Activating the Wnt/β-Catenin Signaling Pathway
21 Jul 2025 11:58 GMT
… progression and poor prognosis in pancreatic cancer … RPRD1A), which improves breast cancer cell migration.28 … catenin signaling to promote breast cancer invasiveness.29 Furthermore, … antagonists suppression promotes breast cancer metastasis. Theranostics. …
About
© 1995-2025